Royalty Pharma Ownership 2024 | Who Owns Royalty Pharma Now?
Institutional Ownership
14.32%
Insider Ownership
12.97%
Retail Ownership
72.71%
Institutional Holders
177.00
Royalty Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 9.84% | 0.09% | 44,133,446 | -84,439 | -0.19% | 1,163,799,031 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.48% | 0.02% | 38,022,381 | 322,699 | 0.86% | 1,002,650,188 | Jun 30, 2024 |
| FMR LLC | 6.22% | 0.05% | 27,886,701 | -5,747,515 | -17.09% | 735,372,306 | Jun 30, 2024 |
| BLACKROCK INC. | 5.13% | 0.01% | 23,017,561 | 1,811,720 | 8.54% | 606,973,091 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 3.65% | 0.34% | 16,352,759 | -310,033 | -1.86% | 431,222,254 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 2.67% | 1.21% | 11,970,058 | 484,511 | 4.22% | 315,650,429 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.44% | 0.53% | 10,931,931 | 115,000 | 1.06% | 288,275,020 | Jun 30, 2024 |
| SWEDBANK AB | 2.41% | 0.38% | 10,813,470 | 2,533,570 | 30.60% | 285,151,204 | Jun 30, 2024 |
| STATE STREET CORP | 2.11% | 0.01% | 9,486,811 | 386,663 | 4.25% | 250,167,206,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.73% | 0.02% | 7,739,281 | -255,818 | -3.20% | 204,084,849 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.53% | 0.02% | 6,848,296 | 300,242 | 4.59% | 180,303,845 | Jun 30, 2024 |
| UNISPHERE ESTABLISHMENT | 1.11% | 1.33% | 5,000,000 | - | - | 131,850,000 | Jun 30, 2024 |
| NORGES BANK | 1.07% | 0.02% | 4,809,343 | 4,809,343 | 100.00% | 126,822,375 | Jun 30, 2024 |
| SIGULER GUFF ADVISERS, LLC | 0.76% | 38.31% | 3,391,754 | - | - | 89,440,553 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.73% | 0.01% | 3,297,277 | 484,144 | 17.21% | 86,949,195,000 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.69% | 0.02% | 3,079,971 | 179,206 | 6.18% | 81,218,630 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.62% | 0.02% | 2,797,327 | 933,604 | 50.09% | 73,765,515 | Jun 30, 2024 |
| GMT CAPITAL CORP | 0.54% | 2.37% | 2,427,100 | 617,200 | 34.10% | 64,002,627 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.52% | 0.03% | 2,350,280 | -2,316,866 | -49.64% | 61,976,884 | Jun 30, 2024 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 0.52% | 2.77% | 2,348,977 | 887,522 | 60.73% | 61,942,523 | Jun 30, 2024 |
Royalty Pharma's largest institutional shareholder is MORGAN STANLEY, holding 9.84% of the company's total share outstanding, currently valued at $1.16B. The top 10 institutional shareholders own together 44.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 0.76% | 38.31% | 3,391,754 | - | - | 89,440,553 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.26% | 5.88% | 1,181,332 | 460,031 | 63.78% | 31,151,725 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.15% | 5.51% | 692,300 | 280,760 | 68.22% | 18,255,951 | Jun 30, 2024 |
| ADVANCED PORTFOLIO MANAGEMENT, LLC | 0.05% | 4.17% | 240,000 | 120,000 | 100.00% | 6,328,800 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.04% | 3.87% | 160,000 | - | - | 4,219,200 | Jun 30, 2024 |
| REGAL PARTNERS LTD | 0.26% | 3.22% | 1,177,601 | 217,774 | 22.69% | 31,053,338 | Jun 30, 2024 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 0.52% | 2.77% | 2,348,977 | 887,522 | 60.73% | 61,942,523 | Jun 30, 2024 |
| TORRAY INVESTMENT PARTNERS LLC | 0.15% | 2.73% | 693,558 | 23,498 | 3.51% | 18,289,124 | Jun 30, 2024 |
| GMT CAPITAL CORP | 0.54% | 2.37% | 2,427,100 | 617,200 | 34.10% | 64,002,627 | Jun 30, 2024 |
| MENLO ADVISORS LLC | 0.03% | 2.16% | 147,885 | 147,885 | 100.00% | 3,899,000 | Jun 30, 2024 |
| PATIENT CAPITAL MANAGEMENT, LLC | 0.32% | 1.99% | 1,424,390 | 4,572 | 0.32% | 37,561,164 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0.42% | 1.81% | 1,866,361 | -384,000 | -17.06% | 49,215,940 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.08% | 1.63% | 338,675 | 327,659 | 2974.39% | 8,930,860 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.12% | 1.38% | 544,697 | - | - | 14,363,660 | Jun 30, 2024 |
| OVERBROOK MANAGEMENT CORP | 0.04% | 1.33% | 200,412 | -8,937 | -4.27% | 5,284,864 | Jun 30, 2024 |
| UNISPHERE ESTABLISHMENT | 1.11% | 1.33% | 5,000,000 | - | - | 131,850,000 | Jun 30, 2024 |
| GENERAL ATLANTIC, L.P. | 0.33% | 1.24% | 1,500,000 | - | - | 39,555,000 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 2.67% | 1.21% | 11,970,058 | 484,511 | 4.22% | 315,650,429 | Jun 30, 2024 |
| HOMESTEAD ADVISERS CORP | 0.41% | 1.21% | 1,859,940 | -32,600 | -1.72% | 49,046,618 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.01% | 1.17% | 60,000 | - | - | 1,582,200 | Jun 30, 2024 |
The largest Royalty Pharma shareholder by % of total assets is SIGULER GUFF ADVISERS, LLC. The company owns 3.39M shares of Royalty Pharma (RPRX), representing 38.31% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.07% | 0.02% | 4,809,343 | 4,809,343 | 100.00% | 126,822,375 | Jun 30, 2024 |
| SWEDBANK AB | 2.41% | 0.38% | 10,813,470 | 2,533,570 | 30.60% | 285,151,204 | Jun 30, 2024 |
| BLACKROCK INC. | 5.13% | 0.01% | 23,017,561 | 1,811,720 | 8.54% | 606,973,091 | Jun 30, 2024 |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 0.36% | 0.32% | 1,637,195 | 1,637,195 | 100.00% | 43,172,832 | Jun 30, 2024 |
| INVESCO LTD. | 0.39% | 0.01% | 1,736,521 | 1,062,833 | 157.76% | 45,792,060 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.62% | 0.02% | 2,797,327 | 933,604 | 50.09% | 73,765,515 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.37% | 0.07% | 1,679,135 | 908,455 | 117.88% | 44,278,790 | Jun 30, 2024 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 0.52% | 2.77% | 2,348,977 | 887,522 | 60.73% | 61,942,523 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.20% | 0.02% | 904,436 | 879,632 | 3546.33% | 23,849,996 | Jun 30, 2024 |
| MAN GROUP PLC | 0.23% | 0.07% | 1,010,468 | 813,343 | 412.60% | 26,646,041 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.46% | 0.12% | 2,057,540 | 753,881 | 57.83% | 54,257,330 | Jun 30, 2024 |
| GMT CAPITAL CORP | 0.54% | 2.37% | 2,427,100 | 617,200 | 34.10% | 64,002,627 | Jun 30, 2024 |
| UBS GROUP AG | 0.29% | 0.01% | 1,285,120 | 585,185 | 83.61% | 33,888,614 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 2.67% | 1.21% | 11,970,058 | 484,511 | 4.22% | 315,650,429 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.73% | 0.01% | 3,297,277 | 484,144 | 17.21% | 86,949,195,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.26% | 5.88% | 1,181,332 | 460,031 | 63.78% | 31,151,725 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.18% | 0.03% | 818,959 | 416,816 | 103.65% | 21,634,672 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.22% | 0.01% | 979,784 | 410,590 | 72.14% | 25,836,905 | Jun 30, 2024 |
| STATE STREET CORP | 2.11% | 0.01% | 9,486,811 | 386,663 | 4.25% | 250,167,206,000 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.08% | 1.63% | 338,675 | 327,659 | 2974.39% | 8,930,860 | Jun 30, 2024 |
As of Jun 30 2024, Royalty Pharma's largest institutional buyer is NORGES BANK. The company purchased 4.81M stocks of RPRX, valued at $126.82M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6.22% | 0.05% | 27,886,701 | -5,747,515 | -17.09% | 735,372,306 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.06% | 0.01% | 279,852 | -2,934,926 | -91.29% | 7,379,697 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.52% | 0.03% | 2,350,280 | -2,316,866 | -49.64% | 61,976,884 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -521,200 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.21% | 0.03% | 945,840 | -510,060 | -35.03% | 24,941,801 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -477,047 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.16% | 0.11% | 714,404 | -437,367 | -37.97% | 18,838,833 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.10% | 0.00% | 430,195 | -402,836 | -48.36% | 11,344,000 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.12% | 0.01% | 524,814 | -399,619 | -43.23% | 13,813,104 | Jun 30, 2024 |
| GENERATE INVESTMENT MANAGEMENT LTD | - | - | - | -396,342 | -100.00% | - | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0.42% | 1.81% | 1,866,361 | -384,000 | -17.06% | 49,215,940 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 3.65% | 0.34% | 16,352,759 | -310,033 | -1.86% | 431,222,254 | Jun 30, 2024 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0.41% | 0.04% | 1,837,338 | -297,566 | -13.94% | 48,450,603 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | - | - | - | -288,378 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.07% | 0.00% | 319,182 | -283,806 | -47.07% | 8,416,830 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -265,334 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.10% | 0.04% | 445,548 | -258,371 | -36.70% | 11,749,101 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.73% | 0.02% | 7,739,281 | -255,818 | -3.20% | 204,084,849 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.08% | 0.01% | 349,748 | -254,997 | -42.17% | 9,222,855 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.09% | 0.02% | 401,526 | -222,513 | -35.66% | 10,588,241 | Jun 30, 2024 |
As of Jun 30 2024, Royalty Pharma's biggest institutional seller is FMR LLC. The company sold -5.75M shares of RPRX, valued at $735.37M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.07% | 0.02% | 4,809,343 | 4,809,343 | 100.00% | 126,822,375 | Jun 30, 2024 |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 0.36% | 0.32% | 1,637,195 | 1,637,195 | 100.00% | 43,172,832 | Jun 30, 2024 |
| MANNING & NAPIER ADVISORS LLC | 0.04% | 0.06% | 195,853 | 195,853 | 100.00% | 5,164,643 | Jun 30, 2024 |
| MENLO ADVISORS LLC | 0.03% | 2.16% | 147,885 | 147,885 | 100.00% | 3,899,000 | Jun 30, 2024 |
| HOHIMER WEALTH MANAGEMENT, LLC | 0.03% | 0.88% | 143,912 | 143,912 | 100.00% | 3,794,959 | Jun 30, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | 0.02% | 0.13% | 100,968 | 100,968 | 100.00% | 2,662,526 | Jun 30, 2024 |
| EMPLOYEES RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.02% | 97,800 | 97,800 | 100.00% | 2,579,000 | Jun 30, 2024 |
| DAI-ICHI LIFE INSURANCE COMPANY, LTD | 0.02% | 0.06% | 94,066 | 94,066 | 100.00% | 2,480,520 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.02% | 0.02% | 81,012 | 81,012 | 100.00% | 2,136,286 | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 0.02% | 0.08% | 75,103 | 75,103 | 100.00% | 1,980,466 | Jun 30, 2024 |
| FJARDE AP-FONDEN (THE FOURTH SWEDISH NATIONAL PENSIONFUND) | 0.02% | 0.02% | 68,050 | 68,050 | 100.00% | 1,794,000 | Jun 30, 2024 |
| AE WEALTH MANAGEMENT LLC | 0.01% | 0.02% | 62,998 | 62,998 | 100.00% | 1,661,266 | Jun 30, 2024 |
| SEARLE & CO. | 0.01% | 0.36% | 57,500 | 57,500 | 100.00% | 1,516,275 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.01% | 0.00% | 48,190 | 48,190 | 100.00% | 1,270,770 | Jun 30, 2024 |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.01% | 0.11% | 45,470 | 45,470 | 100.00% | 1,199,044 | Jun 30, 2024 |
| BDF-GESTION | 0.01% | 0.10% | 38,181 | 38,181 | 100.00% | 1,006,833 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 37,635 | 37,635 | 100.00% | 992,435 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.01% | 0.00% | 33,000 | 33,000 | 100.00% | 870,210 | Jun 30, 2024 |
| MBB PUBLIC MARKETS I LLC | 0.01% | 0.01% | 27,114 | 27,114 | 100.00% | 714,996 | Jun 30, 2024 |
| 0.01% | 0.02% | 25,833 | 25,833 | 100.00% | 681,209 | Jun 30, 2024 | |
| KEYBANK NATIONAL ASSOCIATION/OH | 0.01% | 0.00% | 23,533 | 23,533 | 100.00% | 620,566 | Jun 30, 2024 |
| LA BANQUE POSTALE ASSET MANAGEMENT SA | 0.00% | 0.02% | 20,019 | 20,019 | 100.00% | 527,901 | Jun 30, 2024 |
| M&G PLC | 0.00% | 0.00% | 17,200 | 17,200 | 100.00% | 447,200 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.00% | 0.08% | 16,968 | 16,968 | 100.00% | 447,446 | Jun 30, 2024 |
| FULLERTON FUND MANAGEMENT CO LTD. | 0.00% | 0.02% | 16,002 | 16,002 | 100.00% | 421,973 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | 0.00% | 0.00% | 15,470 | 15,470 | 100.00% | 407,944 | Jun 30, 2024 |
| EPACRIA CAPITAL PARTNERS, LLC | 0.00% | 0.29% | 15,164 | 15,164 | 100.00% | 399,875 | Jun 30, 2024 |
| AVANTAX ADVISORY SERVICES, INC. | 0.00% | 0.00% | 14,089 | 14,089 | 100.00% | 371,527 | Jun 30, 2024 |
| APPLIED FINANCE CAPITAL MANAGEMENT, LLC | 0.00% | 0.02% | 12,892 | 12,892 | 100.00% | 339,962 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.18% | 11,400 | 11,400 | 100.00% | 300,618 | Jun 30, 2024 |
| ENVESTNET PORTFOLIO SOLUTIONS, INC. | 0.00% | 0.00% | 9,616 | 9,616 | 100.00% | 253,576 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.00% | 0.00% | 8,420 | 8,420 | 100.00% | 222,035 | Jun 30, 2024 |
| ONEASCENT WEALTH MANAGEMENT LLC | 0.00% | 0.11% | 7,963 | 7,963 | 100.00% | 210,000 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | 0.00% | 4,997 | 4,997 | 100.00% | 131,771 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 3,006 | 3,006 | 100.00% | 79,268 | Jun 30, 2024 |
| GLADIUS CAPITAL MANAGEMENT LP | 0.00% | 0.00% | 1,208 | 1,208 | 100.00% | 31,855 | Jun 30, 2024 |
| ZYNERGYRETIREMENTPLANNINGLLC | 0.00% | 0.02% | 748 | 748 | 100.00% | 19,725 | Jun 30, 2024 |
| WHITTIER TRUST CO | 0.00% | 0.00% | 484 | 484 | 100.00% | 12,758 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | 0.00% | 206 | 206 | 100.00% | 5,433 | Jun 30, 2024 |
| PINERIDGE ADVISORS LLC | - | 0.00% | 170 | 170 | 100.00% | 4,492 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | - | 0.00% | 147 | 147 | 100.00% | 3,876 | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | - | 0.00% | 73 | 73 | 100.00% | 1,925 | Jun 30, 2024 |
| CULLEN/FROST BANKERS, INC. | - | - | 60 | 60 | 100.00% | 1,582 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | - | 0.00% | 49 | 49 | 100.00% | 1,292 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | - | - | 28 | 28 | 100.00% | 738 | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | - | - | 27 | 27 | 100.00% | 1,000 | Jun 30, 2024 |
| GRADIENT INVESTMENTS LLC | - | - | 19 | 19 | 100.00% | 501 | Jun 30, 2024 |
| HARBOR INVESTMENT ADVISORY, LLC | - | - | 4 | 4 | 100.00% | 105 | Jun 30, 2024 |
Royalty Pharma's largest new institutional shareholder by number of shares is NORGES BANK, purchased 4.81M shares, valued at $126.82M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -521,200 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -477,047 | -100.00% | - | Jun 30, 2024 |
| GENERATE INVESTMENT MANAGEMENT LTD | - | - | - | -396,342 | -100.00% | - | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | - | - | - | -288,378 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -265,334 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -137,000 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -130,188 | -100.00% | - | Jun 30, 2024 |
| MYCIO WEALTH PARTNERS, LLC | - | - | - | -113,652 | -100.00% | - | Jun 30, 2024 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | - | - | - | -92,452 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -67,314 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -65,582 | -100.00% | - | Jun 30, 2024 |
| TAIKA CAPITAL, LP | - | - | - | -43,740 | -100.00% | - | Jun 30, 2024 |
| WEALTHFRONT ADVISERS LLC | - | - | - | -33,821 | -100.00% | - | Jun 30, 2024 |
| LINDEN THOMAS ADVISORY SERVICES, LLC | - | - | - | -33,674 | -100.00% | - | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | - | - | - | -33,000 | -100.00% | - | Jun 30, 2024 |
| FINANCIERE DES PROFESSIONNELS - FONDS D,INVESTISSEMENT INC. | - | - | - | -32,931 | -100.00% | - | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | - | - | - | -32,836 | -100.00% | - | Jun 30, 2024 |
| ADVISORY RESOURCE GROUP | - | - | - | -27,121 | -100.00% | - | Jun 30, 2024 |
| POINT72 HONG KONG LTD | - | - | - | -26,789 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -22,866 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -17,841 | -100.00% | - | Jun 30, 2024 |
| AGF MANAGEMENT LTD | - | - | - | -16,657 | -100.00% | - | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -15,717 | -100.00% | - | Jun 30, 2024 |
| CLEARALPHA TECHNOLOGIES LP | - | - | - | -13,137 | -100.00% | - | Jun 30, 2024 |
| BALLENTINE PARTNERS, LLC | - | - | - | -12,541 | -100.00% | - | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | - | - | - | -11,851 | -100.00% | - | Jun 30, 2024 |
| ASB CONSULTORES, LLC | - | - | - | -11,798 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -11,200 | -100.00% | - | Jun 30, 2024 |
| KOSHINSKI ASSET MANAGEMENT, INC. | - | - | - | -10,671 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -10,190 | -100.00% | - | Jun 30, 2024 |
| SAYBROOK CAPITAL /NC | - | - | - | -9,000 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -8,973 | -100.00% | - | Jun 30, 2024 |
| ETHIC INC. | - | - | - | -8,745 | -100.00% | - | Jun 30, 2024 |
| AXQ CAPITAL, LP | - | - | - | -7,900 | -100.00% | - | Jun 30, 2024 |
| US FINANCIAL ADVISORS, LLC | - | - | - | -7,815 | -100.00% | - | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | - | - | - | -7,576 | -100.00% | - | Jun 30, 2024 |
| LAKE STREET ADVISORS GROUP, LLC | - | - | - | -7,464 | -100.00% | - | Jun 30, 2024 |
| COMMERCE BANK | - | - | - | -7,379 | -100.00% | - | Jun 30, 2024 |
| ARGENT TRUST CO | - | - | - | -7,259 | -100.00% | - | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | - | - | - | -7,197 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -6,800 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -6,672 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -3,500 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -3,059 | -100.00% | - | Jun 30, 2024 |
| GRAYHAWK INVESTMENT STRATEGIES INC. | - | - | - | -1,844 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -1,518 | -100.00% | - | Jun 30, 2024 |
| JOHNSON FINANCIAL GROUP, INC. | - | - | - | -350 | -100.00% | - | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | - | - | - | -204 | -100.00% | - | Jun 30, 2024 |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | - | - | - | -95 | -100.00% | - | Jun 30, 2024 |
| FIRST PACIFIC FINANCIAL | - | - | - | -87 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -51 | -100.00% | - | Jun 30, 2024 |
| WR WEALTH PLANNERS, LLC | - | - | - | -49 | -100.00% | - | Jun 30, 2024 |
| ADVISORNET FINANCIAL, INC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Royalty Pharma's largest sold out institutional shareholder by shares sold is POINT72 ASSET MANAGEMENT, L.P., sold -0.52M shares, valued at -, as of undefined.
Royalty Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 1.92% | 1,000,000 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 1.53% | 800,000 | - | - | Mar 31, 2024 |
| Tax-Managed Multi-Cap Growth Portfolio | 1.33% | 35,581 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.96% | 500,000 | - | - | Mar 31, 2024 |
| DELAWARE GROUP INCOME FUNDS | 0.78% | 25,011,000 | - | - | Jan 31, 2024 |
| DELAWARE VIP TRUST | 0.71% | 2,570,000 | - | - | Mar 28, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.62% | 5,300,000 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.62% | 5,300,000 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.51% | 265,850 | - | - | Mar 31, 2024 |
| Nuveen Core Equity Alpha Fund | 0.49% | 35,000 | - | - | Mar 31, 2024 |
| ADVENT CONVERTIBLE & INCOME FUND | 0.48% | 1,659,000 | - | - | Jan 31, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.40% | 653,600 | - | - | Feb 29, 2024 |
| BNY Mellon Investment Funds VII, Inc. | 0.31% | 325,000 | - | - | Jan 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.29% | 6,638,000 | 2,335,000 | 54.26% | Mar 28, 2024 |
| BNY Mellon Investment Funds VII, Inc. | 0.28% | 325,000 | - | - | Apr 30, 2022 |
| PUTNAM FOCUSED INTERNATIONAL EQUITY FUND | 0.28% | 168,402 | - | - | Jan 31, 2024 |
| BNY Mellon Absolute Insight Funds, Inc. | 0.28% | 4,242,000 | - | - | Apr 30, 2022 |
| Humankind Benefit Corp | 0.27% | 5,962 | 524 | 9.64% | Dec 31, 2023 |
| BNY Mellon Investment Funds VI | 0.25% | 325,000 | 325,000 | - | Feb 29, 2024 |
| ULTRA SERIES FUND | 0.25% | 450,000 | - | - | Mar 31, 2024 |
| PPM Funds | 0.23% | 184,000 | - | - | Mar 31, 2024 |
| BNY Mellon Absolute Insight Funds, Inc. | 0.23% | 4,242,000 | - | - | Jan 31, 2024 |
| CALVERT VARIABLE SERIES INC | 0.22% | 431,000 | - | - | Mar 31, 2024 |
| Natixis ETF Trust | 0.22% | 45,000 | - | - | Mar 31, 2024 |
| DELAWARE GROUP ADVISER FUNDS | 0.22% | 9,196,000 | - | - | Jan 31, 2024 |
| DOMINI INVESTMENT TRUST | 0.21% | 1,250,000 | - | - | Jan 31, 2024 |
| DOMINI INVESTMENT TRUST | 0.21% | 1,250,000 | - | - | Jan 31, 2024 |
| Core Bond Portfolio | 0.21% | 1,588,000 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.19% | 43,026 | - | - | Jan 31, 2024 |
| Nuveen S&P 500 Dynamic Overwrite Fund | 0.18% | 5,318 | - | - | Mar 31, 2024 |
| OPTIMUM FUND TRUST | 0.17% | 7,625,000 | - | - | Mar 28, 2024 |
| CALVERT VARIABLE SERIES INC | 0.17% | 332,000 | - | - | Mar 31, 2024 |
| Federated Hermes Total Return Series, Inc. | 0.17% | 21,600,000 | - | - | Feb 29, 2024 |
| CALVERT SOCIAL INVESTMENT FUND | 0.17% | 7,640,000 | - | - | Mar 31, 2024 |
| Virtus Global Multi-Sector Income Fund | 0.17% | 258,000 | - | - | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.16% | 190,000 | - | - | Mar 28, 2024 |
| Core Bond Portfolio | 0.16% | 1,222,000 | - | - | Mar 31, 2024 |
| PPM Funds | 0.16% | 125,000 | - | - | Mar 31, 2024 |
| DELAWARE VIP TRUST | 0.15% | 545,000 | - | - | Mar 28, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.15% | 670,000 | - | - | Mar 31, 2024 |
| MORGAN STANLEY VARIABLE INVESTMENT SERIES | 0.14% | 75,000 | - | - | Jun 30, 2023 |
| MORGAN STANLEY VARIABLE INVESTMENT SERIES | 0.14% | 75,000 | - | - | Jun 30, 2023 |
| Virtus Total Return Fund Inc. | 0.14% | 271,000 | - | - | Feb 29, 2024 |
| VANGUARD WELLESLEY INCOME FUND | 0.14% | 48,265,000 | - | - | Mar 31, 2024 |
| VANGUARD WELLESLEY INCOME FUND | 0.14% | 48,265,000 | -48,265,000 | -50.00% | Mar 31, 2024 |
| ULTRA SERIES FUND | 0.14% | 250,000 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.13% | 5,695,000 | - | - | Dec 31, 2023 |
| CALVERT SOCIAL INVESTMENT FUND | 0.13% | 5,884,000 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.13% | 3,158,000 | - | - | Jan 31, 2024 |
| MADISON FUNDS | 0.13% | 750,000 | - | - | Jan 31, 2024 |
| BNY Mellon Absolute Insight Funds, Inc. | 0.12% | 2,258,000 | - | - | Jan 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.12% | 2,918,000 | - | - | Jan 31, 2024 |
| BlackRock Multi-Sector Opportunities Trust | 0.11% | 195,000 | - | - | Dec 31, 2023 |
| BlackRock Multi-Sector Opportunities Trust | 0.11% | 195,000 | - | - | Dec 31, 2023 |
| PPM Funds | 0.11% | 91,000 | - | - | Mar 31, 2024 |
| GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | 0.11% | 2,100,000 | - | - | Feb 29, 2024 |
| GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | 0.11% | 2,100,000 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.11% | 44,555,000 | - | - | Feb 29, 2024 |
| VIRTUS VARIABLE INSURANCE TRUST | 0.10% | 162,000 | - | - | Mar 28, 2024 |
| DELAWARE GROUP INCOME FUNDS | 0.10% | 3,175,000 | - | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.10% | 3,185,000 | - | - | Mar 31, 2024 |
| Engine No. 1 ETF Trust | 0.09% | 5,562 | -144 | -2.52% | Jan 31, 2024 |
| JANUS ASPEN SERIES | 0.09% | 3,923,000 | - | - | Dec 31, 2023 |
| AMG Funds IV | 0.09% | 265,000 | - | - | Jan 31, 2024 |
| Ultimus Managers Trust | 0.09% | 1,000,000 | - | - | Feb 29, 2024 |
| MADISON FUNDS | 0.09% | 500,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP ADVISER FUNDS | 0.08% | 3,376,000 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.08% | 323,000 | - | - | Mar 28, 2024 |
| Invesco Bond Fund | 0.08% | 146,000 | - | - | Feb 29, 2024 |
| Guggenheim Variable Funds Trust | 0.08% | 310,000 | - | - | Dec 31, 2023 |
| Guggenheim Variable Funds Trust | 0.08% | 310,000 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.08% | 32,164,819 | -6,045,366 | -15.82% | Mar 31, 2024 |
| GUGGENHEIM FUNDS TRUST | 0.07% | 42,610,000 | - | - | Dec 31, 2023 |
| GUGGENHEIM FUNDS TRUST | 0.07% | 42,400,000 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.07% | 22,254,000 | - | - | Dec 31, 2023 |
| BlackRock Multi-Sector Opportunities Trust II | 0.07% | 85,000 | - | - | Sep 30, 2023 |
| BlackRock Multi-Sector Opportunities Trust II | 0.07% | 85,000 | - | - | Sep 30, 2023 |
| JANUS ASPEN SERIES | 0.07% | 3,046,000 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.07% | 72,542,000 | -11,350,000 | -13.53% | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.07% | 8,196 | - | - | Mar 31, 2024 |
| Invesco Bond Fund | 0.07% | 126,000 | - | - | Feb 29, 2024 |
| CALVERT FUND | 0.07% | 4,000,000 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.07% | 166,000 | - | - | Mar 31, 2024 |
| DELAWARE POOLED TRUST | 0.07% | 70,000 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY INVESTMENT TRUST | 0.06% | 9,163,000 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.06% | 4,172,000 | - | - | Feb 29, 2024 |
| PPM Funds | 0.06% | 50,000 | - | - | Mar 31, 2024 |
| Federated Hermes Managed Pool Series | 0.06% | 790,000 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.06% | 1,411,683 | -49,015 | -3.36% | Mar 31, 2024 |
| DOMINI INVESTMENT TRUST | 0.06% | 350,000 | - | - | Jan 31, 2024 |
| Calvert Management Series | 0.06% | 598,000 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.06% | 245,000 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.06% | 45,000 | - | - | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,053,455 | - | - | Jan 31, 2024 |
| VIRTUS OPPORTUNITIES TRUST | 0.05% | 13,644,000 | - | - | Feb 29, 2024 |
| JOHN HANCOCK INCOME SECURITIES TRUST | 0.05% | 157,000 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INCOME SECURITIES TRUST | 0.05% | 157,000 | - | - | Jan 31, 2024 |
| CALVERT FUND | 0.05% | 2,772,000 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.05% | 14,211,000 | - | - | Dec 31, 2023 |
| Voya BALANCED PORTFOLIO INC | 0.05% | 68,000 | - | - | Mar 31, 2024 |
Royalty Pharma's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 1.00M shares, compromising 1.92% of its total assets.
Royalty Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 177 | -53.79% |
| 31 Mar, 24 | 383 | 4.64% |
| 31 Dec, 23 | 366 | 14.73% |
| 30 Sep, 23 | 319 | -3.04% |
| 30 Jun, 23 | 329 | -0.60% |
| 31 Mar, 23 | 331 | -1.49% |
| 31 Dec, 22 | 336 | 6.33% |
| 30 Sep, 22 | 316 | 10.49% |
| 30 Jun, 22 | 286 | 1.42% |
| 31 Mar, 22 | 282 | 4.06% |
| 31 Dec, 21 | 271 | 12.45% |
| 30 Sep, 21 | 241 | -0.41% |
| 30 Jun, 21 | 242 | 11.01% |
| 31 Mar, 21 | 218 | 8.46% |
| 31 Dec, 20 | 201 | 45.65% |
| 30 Sep, 20 | 138 | 10.40% |
| 30 Jun, 20 | 125 | 12400.00% |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | 1 | - |
As of 30 Jun 24, 177 institutions are holding Royalty Pharma's shares, representing a decrease of -53.79% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 64,248,678 | -79.10% |
| 31 Mar, 24 | 307,482,514 | 0.71% |
| 31 Dec, 23 | 305,308,275 | 4.62% |
| 30 Sep, 23 | 291,835,068 | -6.34% |
| 30 Jun, 23 | 311,586,298 | 4.53% |
| 31 Mar, 23 | 298,094,298 | 0.35% |
| 31 Dec, 22 | 297,069,206 | 0.36% |
| 30 Sep, 22 | 296,001,895 | 1.94% |
| 30 Jun, 22 | 290,377,130 | 7.77% |
| 31 Mar, 22 | 269,435,779 | 0.69% |
| 31 Dec, 21 | 267,599,536 | 1.39% |
| 30 Sep, 21 | 263,941,478 | 5.79% |
| 30 Jun, 21 | 249,496,709 | 0.94% |
| 31 Mar, 21 | 247,181,124 | 7.47% |
| 31 Dec, 20 | 230,000,932 | 44.50% |
| 30 Sep, 20 | 159,167,608 | 6.05% |
| 30 Jun, 20 | 150,086,346 | 1000575540.00% |
| 31 Mar, 20 | 15 | - |
| 31 Dec, 19 | 15 | - |
| 30 Sep, 19 | 15 | - |
| 30 Jun, 19 | 15 | - |
| 31 Mar, 19 | 15 | - |
Royalty Pharma (RPRX) has 64.25M shares outstanding as of 30 Jun 24, down -79.10% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 14.32% | 0.30% |
| 31 Mar, 24 | 68.70% | 1.48% |
| 31 Dec, 23 | 68.08% | 1.62% |
| 30 Sep, 23 | 64.79% | 1.33% |
| 30 Jun, 23 | 69.92% | 1.56% |
| 31 Mar, 23 | 66.90% | 1.45% |
| 31 Dec, 22 | 67.83% | 1.49% |
| 30 Sep, 22 | 67.38% | 1.52% |
| 30 Jun, 22 | 66.55% | 1.73% |
| 31 Mar, 22 | 62.09% | 1.59% |
| 31 Dec, 21 | 62.49% | 1.64% |
| 30 Sep, 21 | 61.64% | 1.66% |
| 30 Jun, 21 | 60.95% | 1.52% |
| 31 Mar, 21 | 63.42% | 1.81% |
| 31 Dec, 20 | 59.26% | 3.20% |
| 30 Sep, 20 | 43.02% | 2.39% |
| 30 Jun, 20 | 42.40% | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
As of 30 Jun 24, Royalty Pharma is held by 14.32% institutional shareholders, representing a 0.30% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | -57.99% |
| 31 Mar, 24 | 219 | -2.67% |
| 31 Dec, 23 | 225 | 32.35% |
| 30 Sep, 23 | 170 | -6.59% |
| 30 Jun, 23 | 182 | -1.09% |
| 31 Mar, 23 | 184 | -3.16% |
| 31 Dec, 22 | 190 | 7.95% |
| 30 Sep, 22 | 176 | 9.32% |
| 30 Jun, 22 | 161 | -10.06% |
| 31 Mar, 22 | 179 | 7.83% |
| 31 Dec, 21 | 166 | 26.72% |
| 30 Sep, 21 | 131 | -7.75% |
| 30 Jun, 21 | 142 | 7.58% |
| 31 Mar, 21 | 132 | -17.50% |
| 31 Dec, 20 | 160 | 66.67% |
| 30 Sep, 20 | 96 | -20.66% |
| 30 Jun, 20 | 121 | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | - |
92 institutional shareholders have increased their position in RPRX stock as of 30 Jun 24 compared to 219 in the previous quarter (a -57.99% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 54 | -53.45% |
| 31 Mar, 24 | 116 | 7.41% |
| 31 Dec, 23 | 108 | -6.09% |
| 30 Sep, 23 | 115 | 7.48% |
| 30 Jun, 23 | 107 | 5.94% |
| 31 Mar, 23 | 101 | -0.98% |
| 31 Dec, 22 | 102 | 15.91% |
| 30 Sep, 22 | 88 | 11.39% |
| 30 Jun, 22 | 79 | 31.67% |
| 31 Mar, 22 | 60 | -10.45% |
| 31 Dec, 21 | 67 | -12.99% |
| 30 Sep, 21 | 77 | 28.33% |
| 30 Jun, 21 | 60 | 9.09% |
| 31 Mar, 21 | 55 | 129.17% |
| 31 Dec, 20 | 24 | 33.33% |
| 30 Sep, 20 | 18 | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
54 institutional shareholders have reduced their position in RPRX stock as of 30 Jun 24 compared to 116 in the previous quarter (a -53.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 177 | -53.79% | 64,248,678 | -79.10% | 14.32% | 0.30% | 92 | -57.99% | 54 | -53.45% |
| 31 Mar, 24 | 383 | 4.64% | 307,482,514 | 0.71% | 68.70% | 1.48% | 219 | -2.67% | 116 | 7.41% |
| 31 Dec, 23 | 366 | 14.73% | 305,308,275 | 4.62% | 68.08% | 1.62% | 225 | 32.35% | 108 | -6.09% |
| 30 Sep, 23 | 319 | -3.04% | 291,835,068 | -6.34% | 64.79% | 1.33% | 170 | -6.59% | 115 | 7.48% |
| 30 Jun, 23 | 329 | -0.60% | 311,586,298 | 4.53% | 69.92% | 1.56% | 182 | -1.09% | 107 | 5.94% |
| 31 Mar, 23 | 331 | -1.49% | 298,094,298 | 0.35% | 66.90% | 1.45% | 184 | -3.16% | 101 | -0.98% |
| 31 Dec, 22 | 336 | 6.33% | 297,069,206 | 0.36% | 67.83% | 1.49% | 190 | 7.95% | 102 | 15.91% |
| 30 Sep, 22 | 316 | 10.49% | 296,001,895 | 1.94% | 67.38% | 1.52% | 176 | 9.32% | 88 | 11.39% |
| 30 Jun, 22 | 286 | 1.42% | 290,377,130 | 7.77% | 66.55% | 1.73% | 161 | -10.06% | 79 | 31.67% |
| 31 Mar, 22 | 282 | 4.06% | 269,435,779 | 0.69% | 62.09% | 1.59% | 179 | 7.83% | 60 | -10.45% |
| 31 Dec, 21 | 271 | 12.45% | 267,599,536 | 1.39% | 62.49% | 1.64% | 166 | 26.72% | 67 | -12.99% |
| 30 Sep, 21 | 241 | -0.41% | 263,941,478 | 5.79% | 61.64% | 1.66% | 131 | -7.75% | 77 | 28.33% |
| 30 Jun, 21 | 242 | 11.01% | 249,496,709 | 0.94% | 60.95% | 1.52% | 142 | 7.58% | 60 | 9.09% |
| 31 Mar, 21 | 218 | 8.46% | 247,181,124 | 7.47% | 63.42% | 1.81% | 132 | -17.50% | 55 | 129.17% |
| 31 Dec, 20 | 201 | 45.65% | 230,000,932 | 44.50% | 59.26% | 3.20% | 160 | 66.67% | 24 | 33.33% |
| 30 Sep, 20 | 138 | 10.40% | 159,167,608 | 6.05% | 43.02% | 2.39% | 96 | -20.66% | 18 | - |
| 30 Jun, 20 | 125 | 12400.00% | 150,086,346 | 1000575540.00% | 42.40% | - | 121 | - | - | - |
| 31 Mar, 20 | 1 | - | 15 | - | - | - | - | - | - | - |
| 31 Dec, 19 | 1 | - | 15 | - | - | - | - | - | - | - |
| 30 Sep, 19 | 1 | - | 15 | - | - | - | - | - | - | - |
| 30 Jun, 19 | 1 | - | 15 | - | - | - | - | -100.00% | - | - |
| 31 Mar, 19 | 1 | - | 15 | - | - | - | 1 | - | - | - |
Royalty Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Royalty Pharma's stock was made by Coyne Terrance P. on Aug 12 2024, selling 2,000 shares at - per share (valued at -).
Royalty Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | 10 | 1 | 1000.00% |
| Q1 2024 | 3 | 4 | 75.00% |
| Q4 2023 | 4 | 9 | 44.44% |
| Q3 2023 | 2 | 7 | 28.57% |
| Q2 2023 | 19 | 7 | 271.43% |
| Q1 2023 | 4 | 8 | 50.00% |
| Q4 2022 | 3 | 13 | 23.08% |
| Q3 2022 | 3 | 36 | 8.33% |
| Q2 2022 | 9 | 14 | 64.29% |
| Q1 2022 | 5 | 8 | 62.50% |
| Q4 2021 | 6 | 19 | 31.58% |
| Q3 2021 | 5 | 30 | 16.67% |
| Q2 2021 | 22 | 47 | 46.81% |
| Q1 2021 | 5 | 17 | 29.41% |
| Q4 2020 | 12 | 17 | 70.59% |
| Q3 2020 | 5 | 2 | 250.00% |
| Q2 2020 | 69 | 19 | 363.16% |
| Q1 2018 | - | 6 | - |
| Q3 2017 | 2 | - | - |
0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Royalty Pharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 6 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | 6 | 5 | 120.00% |
| Q1 2023 | - | 6 | - |
| Q4 2022 | - | 13 | - |
| Q3 2022 | - | 33 | - |
| Q2 2022 | - | 11 | - |
| Q1 2022 | 1 | 5 | 20.00% |
| Q4 2021 | - | 13 | - |
| Q3 2021 | - | 24 | - |
| Q2 2021 | - | 39 | - |
| Q1 2021 | 1 | 17 | 5.88% |
| Q4 2020 | - | 4 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 10 | - | - |
| Q1 2018 | - | - | - |
| Q3 2017 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Royalty Pharma's stocks.
Royalty Pharma Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| DNA | Ginkgo Bioworks Holdings, Inc. |
| ADPT | Adaptive Biotechnologies Corporation |
| VECT | VectivBio Holding AG |
| IKNA | Ikena Oncology, Inc. |
| IOVA | Iovance Biotherapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| RPHM | Reneo Pharmaceuticals, Inc. |
| CVAC | CureVac N.V. |
| BGNE | BeiGene, Ltd. |
| PRME | Prime Medicine, Inc. |
| KNTE | Kinnate Biopharma Inc. |
| ASND | Ascendis Pharma A/S |
| OCEA | Ocean Biomedical, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
RPRX Ownership FAQ
Who Owns Royalty Pharma?
Royalty Pharma is owned by institutional shareholders (14.32%), insiders (12.97%), and public (72.71%). The largest institutional shareholder of Royalty Pharma is MORGAN STANLEY (9.84% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (1.92% of total shares).
Who are the major institutional shareholders of Royalty Pharma?
Royalty Pharma's major institutional shareholders are MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, BLACKROCK INC., and BAILLIE GIFFORD & CO. The top five shareholders own together 33.30% of the company's share outstanding.
How many Royalty Pharma shareholders are there?
As of Jun 2024, there are 177 institutional shareholders of Royalty Pharma.
What percentage of Royalty Pharma is owned by MORGAN STANLEY?
MORGAN STANLEY owns 44.13M shares of Royalty Pharma, representing 9.84% of the company's total shares outstanding, valued at $1.16B (as of Jun 2024).
What percentage of Royalty Pharma is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 38.02M shares of Royalty Pharma (RPRX), compromising 8.48% of the company, valued at $1B.
What percentage of Royalty Pharma is owned by FMR LLC?
FMR LLC is the third largest holder of Royalty Pharma. The company owns 27.89M of the company's shares outstanding (worth $735.37M).